NEXELL THERAPEUTICS INC (NASD: NEXL-$ 10.63. 52 week range: $4.00 - 67.00. Shares O/S: 18.841 M. Market cap: $ 205.380 M. Originally out of Baxter International, Inc. [BAX-81] and still own about 35% of the company.
Is an early commercial stage biotechnology company that is engaged in the development, manufacture, marketing and distribution of specialized instruments, biologicals, reagents, sterile plastics sets and related products used in ex vivo cell research and therapies. NEXL is able to take stem cells from blood, avoiding bone marrow harvesting, by coating magnetic beads that contain an antibody that is recognized by antigens on cells to isolate cells via magnet and to further recognize healthy cells, grow them and re-introduce those stem cells, with no cancer cells. Since the patient is receiving his/her own cells there are few rejection problems. This is highly attractive to those involved with high dose chemotherapy because the cells re-entering the patient are "cleaned" of cancer cells and are the cells of the patient resulting in nearly nil rejection problems.
Approval for the technology has just recently been approved for use in the United States and represents the launch phase for NEXL's major market and we can likely expect 50%+ growth in sales and the same numbers and perhaps more for the following years.
NEXL's stem cell selection process is the state of the art and is the leader. The company is rated by us as a buy and would transit to a "Strong Buy" upon a break of the even decade number of ten.
We suggest you listen to the www.radiowallstreet.com interview with
L. William McIntosh, President and COO and you will get an excellent overview of NEXL's basic business and the technology of stem cell research in general. Highly recommended. radiowallstreet.com
You may also wish to listen the writer's interview relative to stem cell companies on Radio Wall Street at
radiowallstreet.com. [recommended, but not highly].
AXXel Knutson
www.TradingWeapon.com
axxel@blast.net
This report or comment is published solely for information purposes. It may be a part of a published research report of www.TradingWeapon.com. ["Tradingweapon.com" is the business name for AXXel Knutson, who is a Registered Principal of an independently owned office of Supervisory Jurisdiction [OSJ] with First Allied Securities, Inc. Tradingweapon.com offers all of its securities business through First Allied Securities, Inc., a member of the NASD/SIPC. Bear Stearns Securities Corp. is the clearing agent for First Allied. Securities. Inc. This is the short version of our disclaimer. Please see other comments for our larger disclaimer or email AXXel at axxel@blast.net or drop your email address at www.TradingWeapon.com for the total disclaimer and our free newsletters which contain additional information. |
